Feed BMA
BM

Banco Macro S.A. BMA · NYSE

$63.88 -1.77% (-$1.15)

Summary

63 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 84% a year over the last 3 years.
  • The share price is below the Bulios Fair Price.

What to watch

  • It cut its dividend by 76% last year.
  • Revenue growth is slowing: 2.7% a year over the last 3 years against 58% over 5 years.
  • It missed profit estimates 5 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $63.88
5-year average P/E 9.4 52% higher
P/E today 14.2
Banks - Regional industry median
P/E today 14.2

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 14.2 ARS for 1 ARS of yearly profit. Over the last five years it was 9.4 ARS on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (ARS)

Diluted EPS (ARS)

  • Analyst estimate

Revenue grew by 58% a year over 5 years. Over the last 3 years it grew by 2.7% a year. For the next fiscal year analysts expect revenue to grow by 6.6%. Earnings per share grew by 84% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 ARS of revenue goes

Net profit, industry median (Banks - Regional) 21 ARS

Out of every 100 ARS of revenue, 8.7 ARS is left as net profit.

Profitability in detail

Is it financially healthy?

Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.

Financial health in detail

Does it pay a dividend?

High, at risk
Yield
7.00%
Paid out of profit
100%

You receive $2.64 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $88 is 38% above today's price. 50% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.